Combination Therapy in Pulmonary Artery Hypertension
نویسندگان
چکیده
منابع مشابه
Drug Therapy in Patients with Chronic Thromboembolic Pulmonary Hypertension
Background: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) results from the obstruction of predominantly major pulmonary vessels by organized blood clots and is one of the causes of pulmonary hypertension. The disease is still underdiagnosed and the true prevalence is not clear. The objective of this study was to determine the clinical characteristics and current management of patients w...
متن کاملCombination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
Dasatinib is a small-molecule tyrosine kinase inhibitor used in the treatment of hematological malignancies. Pulmonary arterial hypertension (PAH) is a rare but known complication. The mainstay of treatment is cessation of Dasatinib, and while clinical improvement is rapid, complete hemodynamic resolution of pulmonary hypertension (PH) still remains exceedingly uncommon. We present a case of Da...
متن کاملCombination therapy in pulmonary arterial hypertension: a meta-analysis.
OBJECTIVES It is unclear whether combination therapy is efficient and well tolerated in patients with pulmonary arterial hypertension (PAH). The objective was to analyze completed trials assessing the efficacy and safety of treating PAH with combination therapy. METHODS We performed a meta-analysis of all randomized controlled combination therapy trials that evaluated efficacy and safety in P...
متن کاملPulmonary arterial hypertension: combination therapy in the modern management era.
In support of this approach, I would like to present the case of a 40-yr-old female, who had complained of progressive dyspnoea on exertion during a third pregnancy, becoming particularly noticeable after delivery in March 2005. Her two previous pregnancies had been uneventful and she had no relevant previous medical history. She was initially diagnosed as suffering from fatigue and post-partum...
متن کاملBeyond a single pathway: combination therapy in pulmonary arterial hypertension.
There is a strong rationale for combining therapies to simultaneously target three of the key pathways implicated in the pathogenesis of pulmonary arterial hypertension (PAH). Evidence to support this strategy is growing, and a number of studies have demonstrated that combination therapy, administered as either a sequential or an initial regimen, can improve long-term outcomes in PAH. Dual comb...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Advances in Pulmonary Hypertension
سال: 2008
ISSN: 1933-088X
DOI: 10.21693/1933-088x-7.2.bmi